Brief report - Telomere length is a poor biomarker to predict 1-year mortality or cardiovascular comorbidity in patients with transcatheter aortic valve replacement.
Martin SteinmetzCharlotte SchmitterTobias RadeckeAnja StundlGeorg NickenigChristian SchaeferNadjib SchahabMariuca Vasa-NicoteraJan-Malte SinningPublished in: PloS one (2019)
In elderly patients with severe aortic valve stenosis, leucocyte telomere length did not predict post-procedural survival. The correlation between long telomere length and reduced LVEF in these patients deserves further attention.
Keyphrases
- aortic valve
- transcatheter aortic valve replacement
- aortic stenosis
- ejection fraction
- aortic valve replacement
- transcatheter aortic valve implantation
- end stage renal disease
- newly diagnosed
- prognostic factors
- cardiovascular events
- peritoneal dialysis
- risk factors
- working memory
- early onset
- type diabetes
- heart failure
- patient reported outcomes